Stay updated on Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Sign up to get notified when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Two screenshots show only cosmetic UI adjustments and a loading overlay. Core trial details such as title, condition, interventions, outcomes, enrollment, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T20:58:58.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Released v3.2.0 with a new operating-status notice for the NIH Clinical Center and links to status sources; old v3.1.0 version removed.
    Difference
    1%
    Check dated 2025-10-06T05:23:18.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated page version to v3.1.0 and removed several drug-safety related topics, indicating a reorganization/pruning of content rather than new substantive information.
    Difference
    0.2%
    Check dated 2025-09-29T03:03:21.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1; the Back to Top element was removed (minor UI change).
    Difference
    0.1%
    Check dated 2025-09-14T18:57:25.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T14:08:25.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as a focus on diabetes-related content, while removing outdated location terms and references to previous versions.
    Difference
    2%
    Check dated 2025-08-31T11:40:27.000Z thumbnail image

Stay in the know with updates to Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-weekly vs Placebo add-on to SGLT-2i in T2DM Clinical Trial page.